Latest News

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 19x, you may consider...

Visteon (VC) posted revenue growth forecasts of 4.8% per year, which lags the broader US market average of 10%. Net profit margin came in at 7.6%, slipping from last year’s 13.8%, while earnings are only expected to grow at 7.1% per year compared to the market’s 15.5% pace. Over the past five years, annual earnings grew quickly, but the most recent year saw earnings decline, and shares now trade at $110.22, notably below the company's fair value estimate of $157.77. With decent value metrics...

Key Insights The projected fair value for TORM is kr.225 based on 2 Stage Free Cash Flow to Equity TORM's kr.139 share...

The truth is that if you invest for long enough, you're going to end up with some losing stocks. But long term Croda...

Earlier this week, Verastem Oncology announced promising preliminary data from the Phase 1/2a clinical trial of VS-7375, an oral KRAS G12D inhibitor, in patients with advanced KRAS G12D mutant solid tumors, along with the initiation of a combination cohort with cetuximab. These findings are significant, as there are currently no FDA-approved therapies specifically targeting KRAS G12D mutations in cancer, addressing a critical gap for patients with limited treatment options. We'll explore how...

PowerCell Sweden (OM:PCELL) remains unprofitable, but over the past five years has managed to reduce its annual losses by 26.4%. Looking ahead, analysts forecast a sharp swing to profitability within three years, with profit expected to grow at a rapid 91.51% per year and revenue projected to expand by 23.1% per year, notably outpacing the wider Swedish market. With both profitability and revenue on an upward trajectory, investors are weighing these high growth expectations against a share...

Lea Bank (OM:LEA) delivered a 30.2% annual decline in earnings over the past five years, with net profit margins narrowing to 29.6% from last year’s 31.4%. However, consensus sees revenue rising at 15.4% per year, which outpaces the Swedish market’s 3.6%. Earnings growth is also expected to accelerate by 30.75% per year, with the current share price of SEK12.7 trading below an estimated fair value of SEK17.5. Investors are now turning their attention to these robust growth forecasts as the...

Global Dominion Access (BME:DOM) delivered 5.3% average annual earnings growth over the past five years, but just posted a drop in net profit margin to 2.3% from last year’s 4%. The company also experienced negative earnings growth over the past year. With current revenue forecast to rise at just 2% per year, which lags the Spanish market’s 4.6%, attention is now on a projected turnaround as earnings are expected to accelerate at a strong 22.8% per year, well beyond the industry average. See...

The United Kingdom's FTSE 100 index recently experienced a downturn, influenced by weak trade data from China, underscoring the interconnectedness of global markets and their impact on domestic indices. In such volatile conditions, growth companies with high insider ownership can be particularly intriguing to investors as they often signal strong confidence in the company's prospects from those who know it best.

Key Insights Given the large stake in the stock by institutions, Schroder Real Estate Investment Trust's stock price...

Croma Security Solutions Group plc ( LON:CSSG ) insiders who purchased shares in the last 12 months were richly...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

ISEC Healthcare (Catalist:40T) reported an annual net profit margin of 17%, down from 18.9% the previous year. The company’s five-year average earnings growth stands at 19.9% per year, despite negative earnings growth in the latest period. With no material risks identified and the stock’s present value perceived as compelling, investors are left weighing margin compression and recent earnings softness against the company’s long-term track record and attractive valuation metrics. See our full...

Altisource Portfolio Solutions (ASPS) remains unprofitable but has managed to reduce its annual losses by 33.9% per year over the past five years. While the company’s net income has not turned positive and profit growth has not accelerated recently, its Price-To-Sales Ratio of 0.8x stands well below the peer average of 3.4x and the US Real Estate sector average of 2.6x. Investor attention is likely to center on operational progress and revenue momentum, even as shareholder dilution and...

With a price-to-earnings (or "P/E") ratio of 54.1x CVS Group plc ( LON:CVSG ) may be sending very bearish signals at...

As the European market navigates a mixed landscape, with the pan-European STOXX Europe 600 Index inching higher amid dovish signals from the U.S. Federal Reserve and easing U.S.-China trade tensions, investors are keenly eyeing dividend stocks for their potential to provide steady income. In this environment, selecting strong dividend stocks involves looking for companies with solid financial health and consistent payout histories, which can offer stability amidst economic fluctuations.

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

With the business potentially at an important milestone, we thought we'd take a closer look at Delivery Hero SE's...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...